From posting double-digit growth in the first quarter of 2023 to acquiring a New York.-based multispecialty physician group, here are eight headlines about Optum that Becker's has reported since March 22.
Payer
Pharmaceutical Research and Manufacturers of America says CMS' guidance for Medicare drug price negotiation disadvantages manufacturers and will hurt innovation.
Elevance Health, formerly known as Anthem, does not cover GLP-1 drugs prescribed only for weight loss, except in states that require coverage of the drugs by law.
Independence Blue Cross and Philadelphia-based Penn Medicine are piloting a program that will allow qualifying physicians to skip prior authorization approvals needed for ultrasounds, CT scans and PET scans, The Philadelphia Inquirer reported April 18.
Medicare Advantage enrollees across racial and ethnic groups have similar responses to self-reported patient experience measures, but disparities persist in clinical outcomes.
Advertisement
Anthem Blue Cross Blue Shield and Valley Health have settled a dispute over claims reimbursement out of court.
The White House plans to keep COVID-19 vaccines and treatments free for uninsured individuals through 2024, Politico reported April 18.
Payers have been required to post all of their negotiated rates in publicly available files since July 2022, and most have done so, according to Turquoise Health.
Dozens of payers have posted accessible and complete price transparency data since requirements for payers to publish negotiated rates took effect, according to Turquoise Health.
Effective patient care requires coordination across many different players, ranging from primary care physicians to hospitals, rehab facilities, health plans and more. Unfortunately, data sharing among these disparate stakeholders can often be challenging.